InfuSystem Holdings, Inc.

NYSEAM:INFU Stock Report

Market Cap: US$161.8m

InfuSystem Holdings Past Earnings Performance

Past criteria checks 5/6

InfuSystem Holdings's earnings have been declining at an average annual rate of -4.6%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 11.2% per year. InfuSystem Holdings's return on equity is 1.7%, and it has net margins of 0.7%.

Key information

-4.6%

Earnings growth rate

-5.0%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate11.2%
Return on equity1.7%
Net Margin0.7%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Is It Time To Consider Buying InfuSystem Holdings Inc. (NYSEMKT:INFU)?

Mar 29
Is It Time To Consider Buying InfuSystem Holdings Inc. (NYSEMKT:INFU)?

What Kind Of Shareholders Own InfuSystem Holdings Inc. (NYSEMKT:INFU)?

Mar 15
What Kind Of Shareholders Own InfuSystem Holdings Inc. (NYSEMKT:INFU)?

Calculating The Intrinsic Value Of InfuSystem Holdings Inc. (NYSEMKT:INFU)

Mar 03
Calculating The Intrinsic Value Of InfuSystem Holdings Inc. (NYSEMKT:INFU)

If You Like EPS Growth Then Check Out InfuSystem Holdings (NYSEMKT:INFU) Before It's Too Late

Feb 19
If You Like EPS Growth Then Check Out InfuSystem Holdings (NYSEMKT:INFU) Before It's Too Late

Will InfuSystem Holdings' (NYSEMKT:INFU) Growth In ROCE Persist?

Feb 06
Will InfuSystem Holdings' (NYSEMKT:INFU) Growth In ROCE Persist?

InfuSystem Holdings (NYSEMKT:INFU) Seems To Use Debt Quite Sensibly

Jan 24
InfuSystem Holdings (NYSEMKT:INFU) Seems To Use Debt Quite Sensibly

If You Had Bought InfuSystem Holdings (NYSEMKT:INFU) Shares Three Years Ago You'd Have Earned 625% Returns

Jan 11
If You Had Bought InfuSystem Holdings (NYSEMKT:INFU) Shares Three Years Ago You'd Have Earned 625% Returns

At US$18.99, Is InfuSystem Holdings Inc. (NYSEMKT:INFU) Worth Looking At Closely?

Dec 28
At US$18.99, Is InfuSystem Holdings Inc. (NYSEMKT:INFU) Worth Looking At Closely?

Revenue & Expenses Breakdown
Beta

How InfuSystem Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSEAM:INFU Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231261580
30 Sep 231231590
30 Jun 231181590
31 Mar 231130580
31 Dec 221100560
30 Sep 221080560
30 Jun 22107-1560
31 Mar 221040550
31 Dec 211021510
30 Sep 2110012530
30 Jun 219915490
31 Mar 2110018460
31 Dec 209717450
30 Sep 20947430
30 Jun 20906410
31 Mar 20842400
31 Dec 19811390
30 Sep 19770360
30 Jun 1972-1360
31 Mar 1969-2350
31 Dec 1867-1340
30 Sep 1867-19340
30 Jun 1867-18330
31 Mar 1866-19330
31 Dec 1765-21340
30 Sep 1763-3340
30 Jun 1763-3330
31 Mar 1764-2330
31 Dec 16650330
30 Sep 16672330
30 Jun 16683340
31 Mar 16663340
31 Dec 15653340
30 Sep 15632330
30 Jun 15622320
31 Mar 15612310
31 Dec 14613300
30 Sep 14613290
30 Jun 14593280
31 Mar 14582280
31 Dec 13562280
30 Sep 13541260
30 Jun 13540270

Quality Earnings: INFU has high quality earnings.

Growing Profit Margin: INFU's current net profit margins (0.7%) are higher than last year (0.02%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: INFU has become profitable over the past 5 years, growing earnings by -4.6% per year.

Accelerating Growth: INFU's earnings growth over the past year (4744.4%) exceeds its 5-year average (-4.6% per year).

Earnings vs Industry: INFU earnings growth over the past year (4744.4%) exceeded the Healthcare industry 7.3%.


Return on Equity

High ROE: INFU's Return on Equity (1.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.